Engagement / Document Library / Empowering AI-Enabled Digital Pathology with Easy-to-Deploy Solutions
Empowering AI-Enabled Digital Pathology with Easy-to-Deploy Solutions
Last Updated: Aug 31, 2024
Pathology services, including biopsies and blood work used to diagnose illnesses, are a foundation of modern medical care. Drug discovery relies on pathology to simulate drug mechanisms and to establish biomarkers— molecules in body fluids or tissues that indicate abnormality or signs of disease. Clinical trials also rely on pathology to manage chronic diseases and to measure the efficacy of new pharmaceuticals. Traditionally, pathologists analyze a patient’s tissue or fluid sample by staining cellular structures on a glass slide and using a microscope to identify biomarkers in the sample. If needed, the pathologist requests a second opinion or interpretation of the sample by physically shipping the slide to another pathologist.
To view content, please verify your email or register by entering your email address.
Related Content
I Agree to Share My Information
By submitting this form, you agree to share your personal data with Intel for this business request.
Been Here Before?
Enter your Password below to verify.
Thank You!
Thanks for registering as a member in the Intel® Industry Solution Builders program. Your account has been activated. Please set your password by clicking on the link sent to your registered email address.
Note: If you do not see an email from our site in your inbox, please check your email account's Spam or Junk folder to ensure the message was not filtered. If the message was filtered, please 'Mark as good' or 'Not spam' or 'Add sender to white-list.'